bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.04.21.649509

Comparison of Neural Tracking and Spectral Entropy in Patients with Disorders of Consciousness

Abstract

ObjectivesThis study aims to explore the brain responses of patients with disorders of consciousness (DoC) to natural speech. Specifically, it focuses on a key characteristic of natural speech: the speech envelope. To achieve this, we employed two distinct measures. The first evaluates how effectively the patients brain activity "tracks" the speech envelope, called neural tracking. The second assesses the complexity of the brains responses to the speech stimulus, measured through spectral entropy. These two measures are then compared in their association with the patients clinical diagnosis and their level of behavioral responsiveness, both of which were assessed using the Coma Recovery Scale-Revised (CRS-R). DesignFour patients with DoC participated in this study, during which their brain activity was recorded using electroen-cephalography (EEG). At the same time, they listened to a narrated story in both Dutch and Swedish. Additionally, EEG baseline recordings were collected. We employed a backward modeling approach to evaluate the speech envelopes neural tracking. This technique involves training a model to map the relationship between EEG signals and the corresponding speech envelope. Once the model is trained, it can use unseen EEG data to reconstruct the speech envelope, which is then compared to the original speech envelope to assess how effectively the patient processed the auditory stimulus. For the behavioral assessment, we recalculated the CRS-R score of each patient into the CSR-R index, a more meaningful score that utilizes all the information contained in the CRS-R instead of only the highest scores on each subscale. ResultsOur findings revealed positive correlations between spectral entropy and the CRS-R index, which were more pronounced during the listening conditions than the baseline. While neural tracking of the speech envelope did not correlate with the CRS-R index, it did exhibit a positive association with CRS-R diagnoses, indicating that patients with better clinical diagnoses demonstrated higher levels of neural tracking. Additionally, we identified an interaction effect between spectral entropy and neural tracking. Specifically, higher levels of neural tracking were associated with a stronger positive relationship between spectral entropy and the CRS-R index. In contrast, when neural tracking was lower, this relationship disappeared. ConclusionThis study demonstrated the potential of neural tracking and spectral entropy as complementary tools to investigate patients with DoC. Spectral entropy proved valuable for assessing behavioral responsiveness, while neural tracking shows promise in assessing the DoC diagnosis. Terms: disorders of consciousness (DoC), neural tracking, speech envelope, spectral entropy

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Sonck, R., Laureys, S., Diels, P., Francart, T., Vanthornhout, J.. 2025-04-29. Comparison of Neural Tracking and Spectral Entropy in Patients with Disorders of Consciousness. https://doi.org/10.1101/2025.04.21.649509

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗